Clinical Trials Logo

Citation(s)

  •   Amon M, Busin M
    Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. Int Ophthalmol. 2012 Oct;32(5):507-17. Epub 2012 Jun 16. Review.

Details for clinical trial NCT01724892